Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Julia Chocarro"'
Autor:
Sonia Burgaz, Elisa Navarro, Santiago Rodríguez-Carreiro, Carmen Navarrete, Martin Garrido-Rodríguez, Isabel Lastres-Becker, Julia Chocarro, José L. Lanciego, Eduardo Muñoz, Javier Fernández-Ruiz
Publikováno v:
Behavioral and Brain Functions, Vol 20, Iss 1, Pp 1-16 (2024)
Abstract Background The cannabigerol derivative VCE-003.2, which has activity at the peroxisome proliferator-activated receptor-γ has afforded neuroprotection in experimental models of Parkinson’s disease (PD) based on mitochondrial dysfunction (6
Externí odkaz:
https://doaj.org/article/6f04604da77847c5b5d33be525f30c82
Autor:
Alberto J. Rico, Almudena Corcho, Julia Chocarro, Goiaz Ariznabarreta, Elvira Roda, Adriana Honrubia, Patricia Arnaiz, José L. Lanciego
Publikováno v:
Frontiers in Neuroanatomy, Vol 18 (2024)
IntroductionThe presence of a widespread cortical synucleinopathy is the main neuropathological hallmark underlying clinical entities such as Parkinson’s disease with dementia (PDD) and dementia with Lewy bodies (DLB). There currently is a pressing
Externí odkaz:
https://doaj.org/article/6a96e6f1b3464063b996feb48b48365a
Autor:
Julia Chocarro, Alberto Rico, Goiaz Ariznabarreta, Elvira Roda, Adriana Honrubia, Alfonso Vazquez, Patricia Arnaiz, Almudena Corcho, Sergio Maraña, Adriana Leon Villares, Jose Lanciego
Publikováno v:
IBRO Neuroscience Reports, Vol 15, Iss , Pp S384-S385 (2023)
Externí odkaz:
https://doaj.org/article/ba65536b74d441aea3f83f08a2294ab5
Autor:
Ana Fajardo-Serrano, Alberto J. Rico, Elvira Roda, Adriana Honrubia, Sandra Arrieta, Goiaz Ariznabarreta, Julia Chocarro, Elena Lorenzo-Ramos, Alvaro Pejenaute, Alfonso Vázquez, José Luis Lanciego
Publikováno v:
Biomedicines, Vol 10, Iss 4, p 746 (2022)
It is without doubt that the gene therapy field is currently in the spotlight for the development of new therapeutics targeting unmet medical needs. Thus, considering the gene therapy scenario, neurological diseases in general and neurodegenerative d
Externí odkaz:
https://doaj.org/article/50f85da2315b431ab52cf29b705b0c08
Autor:
Ana Fajardo-Serrano, Alberto J. Rico, Elvira Roda, Adriana Honrubia, Sandra Arrieta, Goiaz Ariznabarreta, Julia Chocarro, Elena Lorenzo-Ramos, Alvaro Pejenaute, Alfonso Vázquez, José Luis Lanciego
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 12, p 6389 (2021)
It is without any doubt that precision medicine therapeutic strategies targeting neurodegenerative disorders are currently witnessing the spectacular rise of newly designed approaches based on the use of viral vectors as Trojan horses for the control
Externí odkaz:
https://doaj.org/article/c9b6623b8a9e4eeb9dc33097d3de3679
Autor:
Elena Lorenzo-Ramos, José L. Lanciego, Alberto J. Rico, Sandra Arrieta, Alfonso Vázquez, Julia Chocarro, Elvira Roda, Goiaz Ariznabarreta, Álvaro Pejenaute, Ana Fajardo-Serrano, Adriana Honrubia
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 6389, p 6389 (2021)
International Journal of Molecular Sciences, Vol 22, Iss 6389, p 6389 (2021)
It is without any doubt that precision medicine therapeutic strategies targeting neurodegenerative disorders are currently witnessing the spectacular rise of newly designed approaches based on the use of viral vectors as Trojan horses for the control
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6d41bc298c5ea0f5b99eff55ae876c2
http://europepmc.org/articles/PMC8232322
http://europepmc.org/articles/PMC8232322